| NAME |
RUXOLITINIB 1.5% CREAM,TOP |
| VA GENERIC NAME |
RUXOLITINIB |
| DOSAGE FORM |
CREAM,TOP |
| FDA MED GUIDE |
Ruxolitinib_Cr_(Opzelura)_(2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
1.5 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
% |
| NATIONAL FORMULARY NAME |
RUXOLITINIB CREAM,TOP |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2021-09-30 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
RUXOLITINIB 1.5% TOP CREAM |
| VA PRODUCT IDENTIFIER |
R0437 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
GM |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4040838 |
| EFFECTIVE DATE/TIME |
-
- 2021-09-30 00:00:00
- STATUS: ACTIVE
|
